China’s Geneplus Technology, also known as Gene+, has secured 750 million yuan ($116 million) in a Series C round of financing led by China Construction Bank’s venture unit CCB International, the company said in a statement on Thursday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
